Navigation Links
VetStem Biopharma Shares News of the Successful Treatment of Partially Torn Cruciate Ligament in Young Labrador Retriever with the Pall V-PET™ Platelet Therapy System
Date:10/31/2018

Pippa Rose is a young Labrador retriever. Like most labs, Pippa is energetic, crazy, and fun-loving. When she was around one year old, Pippa suffered a partial tear to the cruciate ligament in her right knee. According to her mom, Kinsley, Pippa was limping constantly and was unable to run or go on walks. Kinsley reported that it broke her heart to see Pippa lie around in pain because it hurt too much to play. Pippa was started on nonsteroidal anti-inflammatories (NSAIDs) however her pain and lameness persisted. Pippa’s veterinarian, Dr. Kristi Laffitte of Pet Star Animal Care of Ruston recommended treatment with Pall Veterinary Platelet Enhancement Therapy (V-PET™) and shortly thereafter, Pippa became Dr. Laffitte’s first patient to be treated with V-PET™.

Pippa Rose received platelet enhancement therapy in August 2018. After a simple blood collection, Pippa’s blood was run through the V-PET™ specialized filter, which is designed to selectively capture platelets to produce a platelet concentrate. The concentrate was injected directly into Pippa’s right knee. Platelets, when exposed to damaged tissue, are triggered to release growth factors that stimulate tissue repair. Since Pippa was both the donor and recipient, there was very little risk of rejection.

Though Pippa was non-weight bearing on her bad leg for weeks prior to receiving platelet therapy, her owner reported that she walked on all fours just a few days after treatment. She was able to return to some of her regular puppy activities including running, going on walks, and playing with her dog and cat siblings. Both Dr. Laffitte and Kinsley reported that Pippa’s overall quality of life had significantly improved.

The Pall V-PET™ kit is distributed by VetStem Biopharma to veterinarians in the United States and Canada. It is a gravity filtration-based platelet therapy kit that produces a platelet concentrate rich in natural healing cells.    Supported by a JAVMA peer-reviewed publication, V-PET™ is an effective regenerative medicine solution for the treatment of joint disease, soft tissue injuries, and chronic wounds. V-PET™ can also be used in conjunction with VetStem Regenerative Cell Therapy to further aid healing.

About Kristi Laffitte, DVM
Dr. Kristi Marie Laffitte grew up in the Calhoun, Louisiana area. She earned her bachelor’s degree in animal science from Louisiana Tech University. She then earned her Doctor of Veterinary Medicine from Louisiana State University in 2016.

About VetStem Biopharma, Inc.
VetStem Biopharma is a veterinarian-lead Company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego, California, currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years and 17,000 treatments by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. In addition to its own portfolio of patents, VetStem holds exclusive global veterinary licenses to a large portfolio of issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/vetstem_biopharma_shares_news_of_the_successful_treatment_of_partially_torn_cruciate_ligament_in_young_labrador_retriever_with_the_pall_v_pet_platelet_therapy_system/prweb15875707.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. Vet-Stem, Inc. Meets New Milestones and Changes Name to VetStem Biopharma
2. VetStem Biopharma -Regenerative Cell Therapy has processed over 11,000 samples
3. Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services.
4. West Coast Bird Dog Champion Wins US Bird Dog Association Western States National Flushing Champion with the help of Stem Cell Therapy by VetStem.
5. Leading Regenerative Veterinary Medicine Company, VetStem Biopharma, Announces the Addition of Dr Ross Rich as the Director of Clinical Development
6. VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering
7. VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities.
8. VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center.
9. VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour
10. VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product
11. VetStem Biopharma, Inc. Founder and CEO, Dr. Robert Harman, to be a Guest Speaker at MSC 2015 Adult Stem Cell Therapy & Regenerative Medicine Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/18/2018)... ... December 18, 2018 , ... Patients with early stages of breast cancer who ... post-treatment versus whole breast irradiation, a new study suggests. , Patients with early stage ... irradiation after removal of the cancerous tumor because there is a 30 to 40 ...
(Date:12/13/2018)... ... 11, 2018 , ... Researchers at Worcester Polytechnic Institute (WPI) ... Clostridium difficile (C. diff), a dangerous and sometimes fatal gastrointestinal infection. The sensor ... used onsite in doctor’s offices and nursing homes, providing results in minutes instead ...
(Date:12/13/2018)... , ... December 12, 2018 , ... Helping conclude Healthy ... new sleek and slim hearing aid within its Vision and Hearing campaign that sets ... , Studies show that despite continued efforts to destigmatize hearing aids over the ...
(Date:12/10/2018)... Shandong, China and SAN DIEGO (PRWEB) , ... ... ... MabPlex International, Ltd., a fully integrated Contract Development and Manufacturing Organization ... line) development, process characterization, conjugation optimization, cGMP manufacturing, and aseptic fill finish ...
Breaking Biology Technology:
(Date:12/19/2018)... (PRWEB) , ... December 19, 2018 , ... NDA Partners ... Reviewer and Compliance Officer at the FDA Center for Devices and Radiological Health (CDRH), ... Partners as an Expert Consultant since 2015, and she has more than 25 years ...
(Date:12/18/2018)... ... 18, 2018 , ... Nativis, Inc. , a clinical ... today announced the publication of an early feasibility study in CNS Oncology suggesting ... The publication of the study, An Early Feasibility Study of the Nativis Voyager® ...
(Date:12/13/2018)... ... 12, 2018 , ... NDA Partners Chief Executive Officer Earle ... Consultants, was recently honored by the American Association of Pharmaceutical Scientists (AAPS) with ... science, technology, engineering, or education and whose contributions to the pharmaceutical sciences community ...
Breaking Biology News(10 mins):